CIK: 0002003147 · Show all filings
Period: Q4 2025
Filing Date: Feb 13, 2026
Total Value ($000): $309,295 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 2,042,242 | $50,852 | 16.4% | $25.03 | 0.0% | COM | 717081103 |
| REGN | REGENERON PHARMACEUTICALS | 52,420 | $40,461 | 13.1% | $678.68 | 0.0% | COM | 75886F107 |
| BNTX | BIONTECH SE | 371,216 | $35,340 | 11.4% | $95.20 | — | SPONSORED ADS | 09075V102 |
| RPRX | ROYALTY PHARMA PLC | 840,650 | $32,483 | 10.5% | $38.13 | 0.0% | SHS CLASS A | G7709Q104 |
| ARGX | ARGENX SE | 35,685 | $30,009 | 9.7% | $840.95 | — | SPONSORED ADR | 04016X101 |
| LEGN | LEGEND BIOTECH CORP | 1,056,668 | $22,972 | 7.4% | $21.74 | — | SPONSORED ADS | 52490G102 |
| ROIV | ROIVANT SCIENCES LTD | 1,028,298 | $22,314 | 7.2% | $19.73 | 0.0% | SHS | G76279101 |
| IONS | IONIS PHARMACEUTICALS INC | 238,477 | $18,866 | 6.1% | $75.30 | 0.0% | COM | 462222100 |
| NTRA | NATERA INC | 78,650 | $18,018 | 5.8% | $208.59 | 0.0% | COM | 632307104 |
| LLY | ELI LILLY & CO | 8,307 | $8,927 | 2.9% | $955.55 | 0.0% | COM | 532457108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 261,615 | $8,141 | 2.6% | $27.43 | 0.0% | COM | 92790C104 |
| MLYS | MINERALYS THERAPEUTICS INC | 210,648 | $7,644 | 2.5% | $40.10 | 0.0% | COM | 603170101 |
| CGON | CG ONCOLOGY INC | 162,005 | $6,726 | 2.2% | $41.38 | 0.0% | COM | 156944100 |
| ABVX | ABIVAX SA | 48,502 | $6,541 | 2.1% | $134.85 | — | SPONSORED ADS | 00370M103 |